SCHEMBL19601690

SCHEMBL19601690

CCc1ccc2cc(CCN)oc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.46
LOXL2 Q9Y4K0 1/20 0.40
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
KDM4E B2RXH2 4/20 0.39
NPC1 O15118 4/20 0.39
ALDH1A1 P00352 4/20 0.39
MAPT P10636 4/20 0.39
RAB9A P51151 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
TP53 P04637 3/20 0.39
HPGD P15428 3/20 0.39
HSD17B10 Q99714 2/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2A6 P11509 2/20 0.39
HTR1A P08908 1/20 0.39
HTR1D P28221 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19604095 0.89 LOXL2 (0.39) TAAR1LOXL2KDM4EALDH1A1MAPT
SCHEMBL10222551 0.84 CYP1A2 (0.45) LOXL2MEN1KMT2AKDM4ENPC1
SCHEMBL22932538 0.83 LOXL2 (0.37) LOXL2MEN1KMT2ANPC1MAPT
SCHEMBL18551227 0.82 MAPT (0.41) TAAR1MEN1KMT2AKDM4EALDH1A1
SCHEMBL16901843 0.79 HDAC6 (0.51) LOXL2MEN1KMT2AKDM4ENPC1
SCHEMBL10670572 0.76 LOXL2 (0.42) TAAR1LOXL2MEN1KMT2AKDM4E
SCHEMBL18067931 0.76 CA12 (0.39) LOXL2MEN1KMT2ANPC1ALDH1A1
SCHEMBL14756189 0.76 LOXL2 (0.42) TAAR1LOXL2MEN1KMT2AKDM4E
SCHEMBL10674648 0.76 LOXL2 (0.42) TAAR1LOXL2MAPTCYP1A2CA12
SCHEMBL14756356 0.76 LOXL2 (0.42) LOXL2CA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3689868-A1 TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS Arvinas Operations, Inc. (US) 2020-08-05 EP disclosed
WO-2017197036-A1 SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION C4 THERAPEUTICS, INC. (US) 2017-11-16 WO disclosed